Protagenic Therapeutics, Inc.
PTIX- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001022899
In the last 90 days, Protagenic Therapeutics, Inc. insiders filed 7 open-market purchases and 0 sales; 2 institutions reported holding it in 13F filings for Q2 2026, worth $25.4K in total; no superinvestor holds it.
Q2 2021 vs. Q1 2021
How the institutions holding Protagenic Therapeutics, Inc. changed between Q1 2021 and Q2 2021.
All holders in Q2 2021All holders in Q1 2021
| Measure | Q1 2021 | Q2 2021 | Change |
|---|---|---|---|
| Holders | 1 | 13 | +12 |
| Shares | 3 | 237.0K | +237.0K (+7,899,233.3%) |
| Value | $0 | $683.0K | +$683.0K |
New holders (12)
Institutions that held Protagenic Therapeutics, Inc. at the end of Q2 2021 but not at the end of Q1 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| State Street Corp | 98,800 | $285.0K | 0.00% |
| Geode Capital Management, LLC | 59,083 | $170.0K | 0.00% |
| Northern Trust Corp | 22,485 | $65.0K | 0.00% |
| Vanguard Group Inc | 20,783 | $60.0K | 0.00% |
| Squarepoint Ops LLC | 19,718 | $57.0K | 0.00% |
| Susquehanna Fundamental Investments, LLC | 12,900 | $37.0K | 0.00% |
| UBS Group AG | 3,012 | $9.00K | 0.00% |
| Bank of America Corp | 4 | $0 | 0.00% |
| Wells Fargo & Company | 77 | $0 | 0.00% |
| Barclays PLC | 113 | $0 | 0.00% |
| Harbor Investment Advisory, LLC | 1 | $0 | 0.00% |
| Banque Cantonale Vaudoise | 1 | $0 | 0.00% |
Sold out (0)
Institutions that held Protagenic Therapeutics, Inc. at the end of Q1 2021 and filed for Q2 2021 without it.
None.